- ►ahajournals.org SM Haffner, AS Greenberg, WM Weston, H … - Circulation, 2002 - Am Heart Assoc Background— Markers of systemic inflammation (eg, C-reactive protein [CRP] and
interleukin-6 [IL-6]) have been proposed to be "nontraditional" risk factors for
cardiovascular disease in patients with type 2 diabetes mellitus. Matrix ... Cited by 822 - Related articles - BL Direct - All 9 versions
- ►ahajournals.org AR Sharrett, CM Ballantyne, SA Coady, G Heiss … - Circulation, 2001 - Am Heart Assoc Methods and Results—— After 10 years follow-up of 12 339 middle-aged
participants free of CHD in the Atherosclerosis Risk in Communities Study
(ARIC), 725 CHD events occurred. The lowest incidence was observed in those ... Cited by 334 - Related articles - All 5 versions
MP Reilly, DJ Rader - Circulation, 2003 - Am Heart Assoc The prevalence of obesity has risen dramatically in the United States. 1 This
has led to a marked increase in the metabolic syndrome (MetSyn), a clustering of
atherosclerotic cardiovascular disease risk factors characterized by ... Cited by 262 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org BEK Klein, R Klein, KE Lee - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Of the 4,423 subjects without diabetes, 6.9% had elevated levels of
glycemia, 18.4% had high blood pressure, 82.7% had high-risk lipid levels
(either high serum total cholesterol or low HDL cholesterol or high ratio ... Cited by 231 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org GA Nichols, TA Hillier, JR Erbey, JB Brown - Diabetes Care, 2001 - Am Diabetes Assoc RESULTS—CHF was prevalent in 11.8% (n = 1,131) of diabetic subjects and 4.5%
(n = 435) of control subjects at baseline. We observed incident cases of CHF in
7.7% of diabetic subjects free of CHF at baseline (650 of 8,460) and in ... Cited by 192 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org G Viberti, SE Kahn, DA Greene, WH Herman, … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A Diabetes Outcome Progression Trial (ADOPT) is a
randomized, double-blind, parallel-group study consisting of a screening visit,
a 4-week placebo run-in, a 4-year treatment period, and an observational ... Cited by 165 - Related articles - BL Direct - All 14 versions
- ►oxfordjournals.org [PDF] PH Whincup, J Danesh, M Walker, L Lennon, … - European heart journal, 2002 - Eur Soc Cardiology Page 1. European Heart Journal (2002) 23, 1764–1770 doi:10.1053/euhj.2001.3237,
available online at http://www.idealibrary.com on ... Cited by 128 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org LA Szczech, PJ Best, E Crowley, MM Brooks, … - Circulation, 2002 - Am Heart Assoc Methods and Results— Morbidity and mortality for the 3608 patients with
multivessel coronary artery disease enrolled in the Bypass Angioplasty
Revascularization Investigation randomized trial and registry were compared ... Cited by 117 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org OC Marroquin, KE Kip, DE Kelley, BD Johnson … - Circulation, 2004 - Am Heart Assoc From the Cardiovascular Institute (OCM, SER), Department of Epidemiology (KEK,
BDJ), and the Division of Endocrinology (DEK), the University of Pittsburgh,
Pittsburgh, Pa; Emory University (LJS), Department of Health Policy & ... Cited by 107 - Related articles - BL Direct - All 10 versions
